Exchange: NASDAQ·Updated 09:50 PM EDT

About IOVA

About

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
975

Frequently Asked Questions

What is Market Cap of Iovance Biotherapeutics Inc?
What is the 52-week high for Iovance Biotherapeutics Inc?
What is the 52-week low for Iovance Biotherapeutics Inc?
What is Iovance Biotherapeutics Inc stock price today?
What was Iovance Biotherapeutics Inc stock price yesterday?
What is the PE ratio of Iovance Biotherapeutics Inc?
What is the Price-to-Book ratio of Iovance Biotherapeutics Inc?
What is the 50-day moving average of Iovance Biotherapeutics Inc?
How many employees does Iovance Biotherapeutics Inc have?

Advertisement|Remove ads.